Received Jul 22, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| RAB | RABIES (IMOVAX) | SANOFI PASTEUR | 1 | — | OT |
patient looking to finish her imovax pre-exposure course. however, her first and only dose was on 6/13/2023 with no reported adverse event.; Initial information received on 18-Jul-2025 regarding an unsolicited valid non-serious case received from a pharmacist. This case involves a patient with unknown age and gender who looked to finish her i Rabies (Hdc) Vaccine [Imovax Rabies] pre-exposure course. however, her first and only dose was on 6/13/2023 with no reported adverse event. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. On 13-Jun-2023, the patient received an unknown dose (dose 1) of suspect Rabies (Hdc) Vaccine, Powder and solvent for suspension for injection (lot number, expiry date and strength not reported) via unknown route in unknown administration site for Prophylactic vaccination (Immunisation) and patient was looking to finish her imovax pre-exposure course. however, her first and only dose was on 6/13/2023 with no reported ae (routine immunisation schedule not administered). Information on the batch number was requested corresponding to the one at time of event occurrence. Reportedly, they wanted to know what was recommended that the patient still received one dose to complete of her series, or did she need two doses 7 days apart to be considered fully vaccinated. Action taken was not applicable. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.